ANDA 78483, held by Synthon Pharms. Zolpidem Tartrate.
As of Nov 16, 2026, ANDA 78483 (Zolpidem Tartrate), held by Synthon Pharms, was first approved by FDA on Jun 6, 2011, with 0 approved supplements and 0 published complete response letters.
| Jun 6, 2011 | Original application | Approved | None posted |
| Apr 12, 2011 | Original application | Approved | None posted |
| Zolpidem Tartrate6.25MG · tablet, extended release;oral | Zolpidem Tartrate | Discontinued |
| Zolpidem Tartrate12.5MG · tablet, extended release;oral | Zolpidem Tartrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters